AI Meets Longevity: New Biomarkers Unveiled at NYU
Excited to be speaking at the AI × Longevity Summit by Longevity Global at NYU Langone BioLabs during NYC Tech Week. I will share work from Albert Einstein College of Medicine and Academy for Health and Lifespan Research focused on translating AI and multi-omics into clinically meaningful aging biomarkers and interventions. June 4–5. If you are serious about AI × longevity, you should be in the room. Registration: https://t.co/obViAMOVVY
FDA Open to Intrinsic Capacity, Demands Sharper IND Proposals
X post Important step forward for geroscience: ARPA-H, XPRIZE, InItiaTe, and the Academy for Geroscience helped sponsor a thoughtful FDA discussion hosted by Reagan-Udall and expertly moderated by Susan. Thanks to Jamie Justice and Andrew Brack for making it happen. The big...
Balanced Longevity Research Shows Real Human Impact
Longevity Science Is Overhyped. But This Research Really Could Change Humanity. We were delighted to have @susandominus with us at the last academy meeting earlier this year. She does gives a balanced take on the latest rejuvenation science. This...
FDA Drugs Show Promise as Future Geromedicines
Check out this article I was apart of @MensHealthMag where I discuss currently approved FDA drugs that are potential geromedicines and our work on centenarians. https://t.co/e95XvnY9fb
New $8M Funding Enables Aging Biomarker Trials
A much needed effort that @Danbelsky and I have now been funded for to support the FAST initiative ($8 million over 18 months): https://t.co/aZsaZuEpoo The goal of this is to provide a set of biomarkers that will tell a person if...